Amedica's SEEplate cervical plate system cleared in US
This article was originally published in Clinica
The SEEplate cervical plate system developed by Amedica has received 510(k) clearance from the US FDA. It is intended for anterior screw fixation of the cervical spine from the second to the seventh cervical vertebrae, as an adjunct to cervical spine fusion. The system can be used in several indications including degenerative disc disease, spinal stenosis and failed prior spine fusion surgery, and is designed to better suit patient anatomy, Salt Lake City, Utah-based Amedica says.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.